CN101176758B - Medicine for treating leucoderma and its preparation method - Google Patents
Medicine for treating leucoderma and its preparation method Download PDFInfo
- Publication number
- CN101176758B CN101176758B CN2007100543525A CN200710054352A CN101176758B CN 101176758 B CN101176758 B CN 101176758B CN 2007100543525 A CN2007100543525 A CN 2007100543525A CN 200710054352 A CN200710054352 A CN 200710054352A CN 101176758 B CN101176758 B CN 101176758B
- Authority
- CN
- China
- Prior art keywords
- medicine
- preparation
- treatment
- skin
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 title claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 42
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 6
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 241001412225 Firmiana simplex Species 0.000 abstract description 3
- 239000000945 filler Substances 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract description 2
- 238000005286 illumination Methods 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 244000287680 Garcinia dulcis Species 0.000 abstract 1
- 241000159213 Zygophyllaceae Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 235000019633 pungent taste Nutrition 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 18
- 206010040882 skin lesion Diseases 0.000 description 18
- 231100000444 skin lesion Toxicity 0.000 description 18
- 230000000694 effects Effects 0.000 description 14
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 12
- 229960001614 levamisole Drugs 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 10
- 229930003268 Vitamin C Natural products 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- 206010047642 Vitiligo Diseases 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 206010025421 Macule Diseases 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000000049 pigment Substances 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002651 drug therapy Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 244000055346 Paulownia Species 0.000 description 3
- 241001446509 Psoralea Species 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000018992 Prunus glandulosa Nutrition 0.000 description 1
- 240000001619 Prunus glandulosa Species 0.000 description 1
- 235000013999 Prunus japonica Nutrition 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 240000001866 Vernicia fordii Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940117895 bakuchiol Drugs 0.000 description 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- OAUREGNZECGNQS-UHFFFAOYSA-N corylifolin Natural products O1C=2C=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=C(O)C=C1 OAUREGNZECGNQS-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940032021 tetramune Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese patent drug for vitligo and a preparation method thereof. The preparation material comprises the technical products of the fresh phoenix tree leaf 800 to less than 1200 portion, the radix-polygoni multiflori 0 to 400 portion, the fructus psoraleae 0 to 300 portion, the white caltrop 0 to 200 portion; the open-eyed preparation method is that, taking the phoenix tree leaf and other material pro rata, mixing, adding water to quench, steam boiling, the remaining juice after removing the slag can be directly used as medicine, and also can be boiled out into the ointment, adding the filler, to make oral medicine. The invention has the advantages of, (1) no pungency, no toxicity, overcoming the pain and the adverse reactions caused by the injection and the skin-grafting illumination, convenient medications, obvious therapeutic effect, high cure rate; (2) being easy to get for the raw material, easy working procedure, low investment, relatively low medical service, being accepted by sufferers.
Description
(1) technical field
The present invention relates to dermopathic medicine of a kind of treatment and preparation method thereof, particularly relate to leukodermic Chinese patent medicine of treatment and preparation method thereof.
(2) background technology
Vitiligo is the difficult dermatosis due to the factors such as common a kind of posteriority hypopigmentation of department of dermatologry or pigment obstacle, have a very wide distribution, and sickness rate has the trend of rising in recent years.At present leukodermic method of treatment and medicine are a lot, but most curative effect can not be satisfactory, and treat with high costsly, and general patient is difficult to afford.Like Therapeutic Method such as " laser ", " skin-grafting ", " freezing ", not only treat with high costsly, also can on skin, stay cicatrix, curative effect is also not fully up to expectations; Multiple therapy of vitiligo medicine, as the speckle removing ball, go Bai Su etc. in process of clinical application, exist the course of treatment long, cure rate is low, the shortcoming of toxic side effect; ZL98101552.2 discloses a kind of externally-applied medicinal composition of treating leucoderma disease; Be considered to certain therapeutic effect; But its required crude drug kind is more; Also have some raw materials to be difficult for obtaining (like Cornu Saigae Tataricae fine powder, Radix Salviae Miltiorrhizae etc.), cause the implementation cost of this scheme high, general patient is difficult to afford.
(3) summary of the invention
The technical problem that the present invention will solve provides a kind of good effect, has no side effect and the leukodermic medicine of the cheap treatment that is easy to get of raw material, and provides the simple method for preparing of this medicine.
For solving the problems of the technologies described above, the technical scheme that the present invention adopts is:
The leukodermic medicine of a kind of treatment is characterized in that, in weight portion, its preparation contains the bright blue or green Folium paulowniae 800 of former medicine～＜1200 parts, 0～400 part of Radix Polygoni Multiflori, 0～300 part of Fructus Psoraleae, 0～200 part of Fructus Atriplicis Sibiricae in raw material.
Contain the bright blue or green Folium paulowniae 800 of the former medicine of former medicine～＜1200 parts, 0～400 part of Radix Polygoni Multiflori, 100～300 parts of Fructus Psoraleaes, 0～200 part of Fructus Atriplicis Sibiricae in the preparation raw material of the leukodermic medicine of described treatment.
Contain the bright blue or green Folium paulowniae 800 of former medicine～＜1200 parts, 200～400 parts of the Radixs Polygoni Multiflori, 0～300 part of Fructus Psoraleae, 0～200 part of Fructus Atriplicis Sibiricae in the preparation raw material of the leukodermic medicine of described treatment.
Contain the bright blue or green Folium paulowniae 800 of former medicine～＜1200 parts, 200～400 parts of Radix Polygoni Multiflori, 0～300 part of Fructus Psoraleae, 100～200 parts of Fructus Atriplicis Sibiricaees in the preparation raw material of the leukodermic medicine of described treatment.
Contain the bright blue or green Folium paulowniae 800 of former medicine～＜1200 parts, 0～400 part of the Radix Polygoni Multiflori, 100～300 parts of Fructus Psoraleaes, 100～200 parts of Fructus Atriplicis Sibiricaees in the preparation raw material of the leukodermic medicine of described treatment.
Contain 900～1100 parts of the bright blue or green Folium paulowniae of former medicine in the preparation raw material of the leukodermic medicine of described treatment, 200～400 parts of Radix Polygoni Multiflori, 100～300 parts of Fructus Psoraleaes, 100～200 parts of Fructus Atriplicis Sibiricaees.
A kind of method for preparing of treating leukodermic medicine may further comprise the steps:
(1) gets bright blue or green Folium paulowniae 1000 weight portions and clean and to dry, and take by weighing all the other each raw materials;
(2) water-cooled that adds 6000～9000 weight portions after each raw materials mix was soaked 2～4 hours, boiled 0.5～2 hour again;
(3) will go up step gained juice and be filtered in the container, after in filtering residue, adding water 0.5～2 weight portion continued and boiling, filter and remove residue gained juice and the merging of aforementioned juice.
Be sub-packed in 30～50ml bottle after gained juice in the above-mentioned steps (3) put cold, pack after the sterilization and be exterior-applied formulation.
With gained juice decocting and concentrating in the above-mentioned steps (3) to the runny plaste shape; Put cool back and add ethanol 200～400 weight portions, left standstill 2～4 hours after slowly stirring, again with its simmer down to thick paste shape; Put the medical filler that cool back adds 0.5～1.0 weight portion, process peroral dosage form.
Above-mentioned medical filler is a medical starch, and said peroral dosage form is a graininess, every heavy 1～2g.
The usage of medicine of the present invention and consumption:
1. oral administration pills or capsule are example with granule (every heavy 1.2g) shape, every day 2 times, each 1; 1 month is a course of treatment, takes continuously 3 months, treat that white macula disappears or skin recover basically normal after; Change into every day 1 time or the next day 1 time, each 1, serve on 3 months to consolidate curative effect;
2. exterior-applied formulation is directly smeared the affected part, and every day 1～2 time, consumption is looked the size of skin lesion and decided, and administration time recovers till the normal color of the leather with skin lesion.
The present invention has actively useful effect:
(1) compare with domestication student Tetramune and X-ray therapy with this Drug therapy vitiligo and have following characteristics: 1. non-stimulated, have no side effect, overcome caused pain and untoward reaction such as injection, skin-grafting illumination; 2. the raw material medicine is easy to obtain, operation is easy, small investment, medical expense are cheap relatively, and the patient can accept.
(2) scientific formulation is reasonable, and each medicine is in step with, and cooperatively interacts, and synergism, therapeutic effect are more remarkable.
Pharmacology analysis of the present invention:
Works such as motherland's medical science " all cause of disease wait opinion ", Golden Mirror of Medicine, " Standards of Diagnosis and Treatment " are discussed vitiligo is existing, and summary is thought the skin QI and blood deficiency, and the qi-blood disharmony damp-stagnancy that becomes a common practice is due to the fur.In recent years; Fast development along with the modern medicine technology; For probing into the leukodermic cause of disease, scientists is constantly carried out deep research from physiology, biology, biochemistry, heredity, immune molecule and cell division and the aspects such as cycle variation and trace element of human body skin, finds that tryrosinase is the synthetic key enzyme of melanin; Be considered to the autoimmune important antigen of vitiligo; And the pathology reason that causes skin pigment to take off mistake is that the tryrosinase of human body is suppressed, and causes functional melanocyte to be subjected to destroy to some extent, and then causes the melanin metabolic process to be obstructed.
But Firmiana platanifolia (Linn. f.) Marsili point-score paulownia, blue or green paulownia, Paulownia, Folium et Ramulus Clerodendri Trichotomi etc., blue or green Folium paulowniae according to the invention is from blue or green tung oil tree, and is very extensive in the growth region of China.Blue or green Folium paulowniae, property is put down bitter in the mouth, and is little nontoxic; Return lung meridian; Contain compositions such as flavonoid glycoside, meso inositol (Myoinosito), natural pigment and other bitter in the mouth element, this type material gets into can play rapidly behind the Cytoplasm regulates cells physiological, biochemical action, activates tryrosinase; Impel melanocyte to recover normal physiological function, thereby reach the leukodermic purpose of treatment.
Radix Polygoni Multiflori, slightly warm in nature, bitter in the mouth, sweet, puckery; Return liver, the heart, kidney channel, its tuber contains anthraquinone derivatives emodin, chrysophanol, chrysophanic acid and lecithin etc., can promote the newborn and growth of cell; The nutrition brains promote enterokinesia, the effect of tool invigorating the liver and kidney, benefiting essence-blood, black beard and hair, bone and muscle strengthening.
Fructus Atriplicis Sibiricae, warm in nature, bitter in the mouth, suffering; Contain multiple alkaloid, glycoside, fatty oil, volatile oil and multiple abundant peroxide breakdown enzyme etc., have the effect that vessel softening, enhancing microcirculation etc. are invigorated blood circulation, obvious anti-aging effects is arranged; Materials for improving vision is made light of one's life by commiting suicide, cicatrix on the removal face, treatment vitiligo.Compendium of Material Medica is said: " it is black to wash one's face, and speckle dispelling is washed the scar skin ulcer.”
Fructus Psoraleae, another name Fructus Psoraleae, Fructus Psoraleae, black paper recklessly, warm in nature, acrid in the mouth, hardship.Contain flavone compound, Coryfolin, Coumarins chemical compound, Radix Angelicae Dahuricae element, Bakuchiol and volatilization wet goods.Pharmacology: ability is coronary artery dilator obviously; Promote the granulocyte growth; Promote the metabolism of dermal melanin, the expansion local vascular improves histotrophic nutrition.The effect of tool kidney invigorating and YANG supporting, helping inspiration to relieve asthma, warm spleen antidiarrheal.
The Radix Angelicae Dahuricae has another name called Radix Angelicae Dahuricae (Radix Heraclei Scabridi), and acrid in the mouth is warm in nature, returns lung, spleen, stomach, large intestine channel.Function: expelling pathogenic wind from the body surface, dispersing cold for relieving pain, sensible, the detumescence and apocenosis of dehumidifying.Modern pharmacological research proves, the effects such as Fructus Psoraleae is analgesic except that having, analgesia, antiinflammatory, can also improve local blood circulation, eliminates pigment in tissue, excessively to pile up, and promotes skin cell metabolism.The Compendium of Material Medica meaning Radix Angelicae Dahuricae " longue skin, moist color can be made face fat ".
Medicine-feeding is in step with, and shows its effect fully, and Fang Jian is imitated grand.
In recent years, almost all there is every day more than 20 a Bai Dianfeng patient from various parts of the country come the inventor to locate to seek medical advice, patient more than 90% arranged, sought medical advice out of admiration for a famous person because of not good at local therapeutic effect.Belong to outpatient service registration according to the inventor and show that from March 10,2006 10 days to 2007 March in, the prescription on individual diagnosis number reaches 8006 person-times, wherein register full and accurate and totally 630 person-times of therapeutic outcome are arranged, the actual patient of seeking medical advice reaches 5008 people.In the middle of these patients with vitiligo of seeking medical advice, after Drug therapy according to the invention, the healing number is 2100 people, accounts for 42%; 1800 people of produce effects account for 36%; Effective 860 people account for 17%; 248 invalid people account for 5%.
The recovery from illness of therapeutic evaluation standard: white macula all disappears, and recovers the normal colour of skin; Produce effects: white macula partly disappears or dwindles, and the area that recovers the normal colour of skin accounts for skin lesion area 75%; Effectively: white macula partly disappears or dwindles, and the area that recovers the normal colour of skin accounts for skin lesion area 10～50%; Invalid: white macula no change or dwindle, the area that recovers the normal colour of skin accounts for skin lesion area＜10%.
Example 1, Wang Lianpeng, the man, 32 years old, Kaifeng park passerby suffered from vitiligo 9 years, and was initial at hands and face, after develop into upper limb and trunk, lower limb also have several, use up all savings in several years, fail to cure, and can't marry and settle down because of suffering from this disease.Bai Dianfeng out of admiration for a famous person sought medical advice to the inventor place at the beginning of calendar year 2001.Use Drug therapy of the present invention after 3 months, white macula is expansion more, tangible pigmentation speckle is arranged between wherein, increases in flakes gradually, and normal color of the leather is recovered in the back.Former 60% skin (mainly being face and upper limb, breast, the back of the body, abdominal part) the skin lesion face that accounts for reverts to about 10%.After again with this medicine treatment treatment 6 months, be almost recovered, cause has been started in recurrence so far after the drug withdrawal, and take a wife and give birth to son.This patient medication nine months altogether, medical care expenses is about totally 700 yuan.
Example 2, Huang Lihua, the woman, the attending doctor, Bai Dianfeng was suffered from 12 years in No. six building, Rui'an City Ni Cheng road, Zhejiang Province, and skin lesion has accounted for 75% of whole skin, almost abandoning cure.Seek medical advice in come out of admiration for a famous person in May, 2000 inventor place.She was facial at that time, cervical region and upper limb exposure portion skin lesion have accounted for 90% of this position, and hospitalization is after 10 days, and former skin lesion begins ruddy, has occurred the pigment point at the pore place, after be with the treatment of going back of trimestral medicine, medicinal intact after, skin lesion has recovered 50%.After again with after this medicine treatment half a year, the exposure portion skin lesion has recovered 80%.After after treatment 3 months again, the former skin lesion that accounts for whole skin 75% is cured, only has several also to recover normal fully, accounts for about 3% of whole skin.Only more than 1,000 yuan of the expenses for medicine in 1 year.
Example 3, Jiang, people from Shijiazhuang City, Hebei Province; Suffered from vitiligo 3 years, PD is very fast, and the skin lesion face has accounted for about 50% of whole skin; Introduce the inventor to locate to seek medical advice through friend; Through treating six months with this medicine, skin lesion recovers normally fully, and only upper lip left side mucosa and skin junction do not return to normal color of the leather.More not recurrence after.
Example 4, Yuan, the middle schoolgirl, Chinese bush cherry people from villages and small towns, Xincai County, Henan Province, abdominal part to abdominal part ditch finds that white macula is surplus January, does not tell the head of a family, the adularescent pubes are found in the back, the about two palms size of skin lesion face, it is female just leads daughter to come the inventor to punish treatment.Accepted this Drug therapy two months, and fully recovered, take bimestrial medicine after treatment again, thoroughly cure, so far not recurrence in 3 years.
Example 5, Zheng, man, Sun Zhao township, Xincai County, Henan Province cadre; Left side cervical region to back side of head skin and hair turns white, and develops into the palm size in three months, once uses multi-treatment; Though the state of an illness is controlled to some extent, skin lesion does not have obvious change, and the back is with the treatment of this medicine; Be clearly better after one month, it is normal that former after two months skin lesion recovers, not recurrence in 3 years so far.
Example 6, Mrs Zhao, the welcome center staff of the Hunan Province People's Government, it is surplus to suffer from Bai Dianfeng 3 years; Seek medical advice and do not heal in many places, the state of an illness has the expansion tendency, and skin lesion has accounted for 40% of whole skin; Damaging part mainly is back and lower limb, introduces through friend, and special trip comes the inventor to punish treatment; With after this medicine treatment half a year, the basic healing, after again remittance purchase three courses of treatment medicine to consolidate curative effect.
(4) specific embodiment
Embodiment 1: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Fructus Atriplicis Sibiricae 200g.
A kind of method for preparing of treating leukodermic medicine, its step is following: 1. get and clean the blue or green Folium paulowniae 1000g of air dried aquatic foods, take by weighing Fructus Atriplicis Sibiricae 200g simultaneously, and mix with bright Folium paulowniae; 2. in above-mentioned compound, add water 8000g, merceration boiled after 3 hours 1 hour; 3. juice is filtered in the container, after in filtering residue, adding water 1000g again and continuing to boil, filter and remove residue gained juice and aforementioned juice merge; 4. with above-mentioned juice decocting and concentrating to the runny plaste shape, put cool back and add 75% ethanol 300ml, left standstill 3 hours after slowly stirring; 5. the runny plaste shape juice simmer down to thick paste shape after will leaving standstill is again put the medical starch that cool back adds 1000g, the granule of processing, and every heavy 1.2g incapsulates after the drying, and this is a peroral dosage form.
With above-mentioned steps 3. in gained juice be sub-packed in the 50ml bottle after putting cold, pack after the sterilization and be exterior-applied formulation.
Embodiment 2: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1195g, Fructus Atriplicis Sibiricae 200g, Fructus Psoraleae 300g.
A kind of method for preparing of treating leukodermic medicine, its step is following: 1. get and clean the blue or green Folium paulowniae 1200g of air dried aquatic foods, take by weighing Fructus Atriplicis Sibiricae 200g, Fructus Psoraleae 300g simultaneously, and mix with bright Folium paulowniae; 2. in above-mentioned compound, add water 7000g, merceration boiled after 2 hours 2 hours; 3. juice is filtered in the container, in filtering residue, adds water 1000g again and continue to boil, merge with aforementioned juice behind the filter and remove residue; 4. with above-mentioned juice decocting and concentrating to the runny plaste shape, put cool back and add 95% ethanol 250ml, left standstill 2 hours after slowly stirring; 5. the runny plaste shape juice simmer down to thick paste shape after will leaving standstill is again put the medical starch that cool back adds 500g, the granule of processing, and every heavy 1g incapsulates after the drying.
With above-mentioned steps 3. in gained juice be sub-packed in the 30ml bottle after putting cold, pack after the sterilization and be exterior-applied formulation.
Embodiment 3: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Atriplicis Sibiricae 100g, Fructus Psoraleae 200g, Radix Polygoni Multiflori 200g.
A kind of method for preparing of treating leukodermic medicine, its step is following: 1. get and clean the blue or green Folium paulowniae 1100g of air dried aquatic foods, take by weighing Fructus Atriplicis Sibiricae 100g, Fructus Psoraleae 200g, Radix Polygoni Multiflori 200g simultaneously, and mix with bright Folium paulowniae; 2. in above-mentioned compound, add water 9000g, merceration boiled after 4 hours 0.5 hour; 3. juice is filtered in the container, in blue or green Folium paulowniae, adds water 500g continued again and boil, merge with aforementioned juice behind the filter and remove residue; 4. with above-mentioned juice decocting and concentrating to the runny plaste shape, put cool back and add 75% ethanol 400ml, left standstill 1 hour after slowly stirring; 5. the runny plaste shape juice simmer down to thick paste shape after will leaving standstill is again put the medical starch that cool back adds 1000g, the granule of processing, and every heavy 1.3g incapsulates after the drying.
With above-mentioned steps 3. in gained juice be sub-packed in the 40ml bottle after putting cold, pack after the sterilization and be exterior-applied formulation.
Embodiment 4: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Fructus Atriplicis Sibiricae 200g, Fructus Psoraleae 300g, Radix Polygoni Multiflori 300g, vitamin C 300g, levamisole 7500mg.
Basically with embodiment 1, difference is its preparation method: vitamin C and levamisole can directly be added in the cream that is boiled at last, and get final product after stirring.
Embodiment 5: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 900g, vitamin C 300g, levamisole 7500mg.
Basically with embodiment 1, difference is its preparation method: vitamin C and levamisole directly are added in the cream that is boiled into, and stir.
Embodiment 6: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g.
Its preparation method is with embodiment 1.
Embodiment 7: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Psoraleae 300g, Radix Polygoni Multiflori 300g, vitamin C 300g, levamisole 7500mg.
Basically with embodiment 1, difference is its preparation method: vitamin C and levamisole directly are added in the cream that is boiled into, and stir.
Embodiment 8: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Fructus Atriplicis Sibiricae 200g, Radix Polygoni Multiflori 300g, levamisole 7500mg, water 9000g.
Basically with embodiment 1, difference is its preparation method: levamisole directly is added in the cream that is boiled into, and stirs.
Embodiment 9: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1190g, Fructus Atriplicis Sibiricae 50g, Fructus Psoraleae 100g, Radix Polygoni Multiflori 200g.
Its preparation method is with embodiment 1.
Embodiment 10: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 850g, Fructus Atriplicis Sibiricae 300g, Fructus Psoraleae 300g, Radix Polygoni Multiflori 400g.
Its preparation method is with embodiment 1.
Embodiment 11: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 950g, Fructus Atriplicis Sibiricae 150g, Fructus Psoraleae 100g, Radix Polygoni Multiflori 100g.
Its preparation method is with embodiment 1.
Embodiment 12: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Atriplicis Sibiricae 100g, Fructus Psoraleae 300g, Radix Polygoni Multiflori 300g, Radix Angelicae Dahuricae 300g.
Its preparation method is with embodiment 1.
Embodiment 13: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Radix Polygoni Multiflori 300g.
Its preparation method is with embodiment 1.
Embodiment 14: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Psoraleae 300g.
Its preparation method is with embodiment 1.
Embodiment 15: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1150g, Fructus Atriplicis Sibiricae 150g.
Its preparation method is with embodiment 1.
Embodiment 16: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 880g, Fructus Atriplicis Sibiricae 50g, Fructus Psoraleae 200g, Radix Polygoni Multiflori 350g.
Its preparation method is with embodiment 1.
Embodiment 17: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 950g, Fructus Atriplicis Sibiricae 150g, Fructus Psoraleae 300g.
Its preparation method is with embodiment 1.
Embodiment 18: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1050g, Fructus Psoraleae 50g, Radix Polygoni Multiflori 50g.
Its preparation method is with embodiment 1.
Embodiment 19: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1150g, Fructus Atriplicis Sibiricae 180g, vitamin C 100g.
Basically with embodiment 1, difference is its preparation method: vitamin C can directly be added in the cream that is boiled into, and stirs.
Embodiment 20: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 820g, Fructus Psoraleae 380g, Radix Polygoni Multiflori 350g, Radix Angelicae Dahuricae 100g, levamisole 6500mg.
Basically with embodiment 1, difference is its preparation method: levamisole directly is added in the cream that is boiled into, and stirs.
Embodiment 21: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1190g, Fructus Atriplicis Sibiricae 80g, Fructus Psoraleae 150g, Radix Polygoni Multiflori 60g.
Its preparation method is with embodiment 1.
Embodiment 22: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Atriplicis Sibiricae 100g, Fructus Psoraleae 250g, Radix Polygoni Multiflori 400g.
Its preparation method is with embodiment 1.
Embodiment 23: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Fructus Psoraleae 280g, Radix Polygoni Multiflori 260g, Fructus Atriplicis Sibiricae 200g, Radix Angelicae Dahuricae 300g.
Its preparation method is with embodiment 1.
Embodiment 24: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Fructus Psoraleae 180g, Radix Angelicae Dahuricae 300g.
Its preparation method is with embodiment 1.
Embodiment 25: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 900g, Fructus Atriplicis Sibiricae 200g, Radix Angelicae Dahuricae 280g.
Its preparation method is with embodiment 1.
Embodiment 26: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1180g, Radix Angelicae Dahuricae 300g.
Its preparation method is with embodiment 1.
Embodiment 27: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1100g, Radix Polygoni Multiflori 380g, Radix Angelicae Dahuricae 250g.
Its preparation method is with embodiment 1.
Embodiment 28: the leukodermic medicine of a kind of treatment, its composition of raw materials is: bright blue or green Folium paulowniae 1000g, Fructus Psoraleae 180g, Radix Polygoni Multiflori 380g, Fructus Atriplicis Sibiricae 200g, Radix Angelicae Dahuricae 280g, vitamin C 280g, levamisole 7000mg.
Basically with embodiment 1, difference is its preparation method: vitamin C and levamisole directly are added in the cream that is boiled into, and stir.
Claims (2)
1. the leukodermic medicine of treatment is characterized in that, the crude drug in its preparation raw material is: bright blue or green Folium paulowniae 1100g, Radix Polygoni Multiflori 300g, Fructus Psoraleae 300g, Fructus Atriplicis Sibiricae 100g and Radix Angelicae Dahuricae 300g.
2. the leukodermic medicine of treatment is characterized in that, the crude drug in its preparation raw material is: bright blue or green Folium paulowniae 1000g, Radix Polygoni Multiflori 260g, Fructus Psoraleae 280g, Fructus Atriplicis Sibiricae 200g and Radix Angelicae Dahuricae 300g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100543525A CN101176758B (en) | 2007-05-08 | 2007-05-08 | Medicine for treating leucoderma and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100543525A CN101176758B (en) | 2007-05-08 | 2007-05-08 | Medicine for treating leucoderma and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101176758A CN101176758A (en) | 2008-05-14 |
| CN101176758B true CN101176758B (en) | 2012-02-01 |
Family
ID=39403279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100543525A Expired - Fee Related CN101176758B (en) | 2007-05-08 | 2007-05-08 | Medicine for treating leucoderma and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101176758B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103655740A (en) * | 2012-09-26 | 2014-03-26 | 刘良柱 | Traditional Chinese medicine preparation for treating leucoderma |
| CN103493933A (en) * | 2013-10-15 | 2014-01-08 | 北京绿源求证科技发展有限责任公司 | Healthcare food-made tea granules for improving leucoderma |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098311A (en) * | 1994-02-02 | 1995-02-08 | 李庆和 | Treat leukodermic Chinese medicine Baiyuwan pill |
| CN1141174A (en) * | 1995-07-24 | 1997-01-29 | 苏国平 | External application lotion for treating vitiligo |
-
2007
- 2007-05-08 CN CN2007100543525A patent/CN101176758B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098311A (en) * | 1994-02-02 | 1995-02-08 | 李庆和 | Treat leukodermic Chinese medicine Baiyuwan pill |
| CN1141174A (en) * | 1995-07-24 | 1997-01-29 | 苏国平 | External application lotion for treating vitiligo |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101176758A (en) | 2008-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991816B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN101879281B (en) | Formula of honey refined gum for treating chloasma and preparation method thereof | |
| CN102988264A (en) | Ginkgo leaf freckle removing whitening cream and preparation method thereof | |
| CN103191313A (en) | Syrup for enriching and nourishing blood and preparation method thereof | |
| CN102988273A (en) | Whitening and freckle-removing Chinese medicinal mask | |
| CN101524437A (en) | Chinese medicinal composition for treating female anemia and preparation method thereof | |
| CN102366541A (en) | Traditional Chinese medicine composition for treatment of diabetes | |
| CN102406867A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN101485820B (en) | Health-care bolus for persons in middle and old age | |
| CN101176758B (en) | Medicine for treating leucoderma and its preparation method | |
| CN102133167B (en) | Freckle removing facial mask made of traditional Chinese medicine and preparation process thereof | |
| CN103156956B (en) | Blood replenishing oral liquid and preparation method thereof | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN102406866A (en) | Traditional Chinese medicine mixture for treating psoriasis | |
| CN101224275B (en) | Chinese traditional medicine for treating chloasma | |
| CN103212037A (en) | Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine | |
| CN102988498B (en) | Medicine composition for treating leucoderma | |
| CN101406641B (en) | Compound medicament for treating vitiligo | |
| CN101244139B (en) | Chinese medicine composition for prevention or adjuvant therapy of cardiovascular disease and method of preparing the same | |
| CN101361909B (en) | Anti-aging traditional Chinese medicine composition for increasing skin oil content and preparation method thereof | |
| CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
| CN105641352A (en) | Medicinal preparation for treating facial stain and application thereof | |
| CN104147186A (en) | Rose essential oil hydrogel plaster and preparation method thereof | |
| CN1475243A (en) | External medicine for treating leucoderma | |
| CN103142757B (en) | Traditional Chinese medicine capsule for treating liver and kidney deficiency after fracture and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120201 Termination date: 20140508 |